The US Food and Drug Administration (FDA) has removed the clinical hold on a trial of Cialis (tadalafil) by Sanofi's consumer ...

Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a ...

Opella reaches study milestone for CialisParis, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and ...

When it comes to men’s health, tadalafil is one of the most talked-about medications out there. Originally developed to treat erectile dysfunction (ED), it’s now known for its many other uses, from ...

Creador is banking on MG’s low-cost platform to shake up key markets like North Asia and Europe. The challenge? Scaling globally while keeping MG’s lean and efficient DNA intact. Creador has ...

Like other medications for the treatment of (ED), Cialis — and its generic version, tadalafil — can cause adverse effects at first. Fortunately, most tadalafil side effects are mild and ...

Three of MG’s upcoming models are expected to be put up on display at the Bharat Mobility Global Expo 2025. MG Motor India is geared up to make a bold statement in 2025 with an impressive lineup ...